Search Constraints
« Previous |
41 - 60 of 81
|
Next »
Search Results
Select an image to start the slideshow
New methods for the synthesis of pharmaceutical azacycles
1 of 20
Hi-JAK-ing the ubiquitin system : the design and physicochemical optimisation of JAK PROTACs
2 of 20
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
3 of 20
The design, synthesis and optimisation of phosphoinositide-3-kinase (PI3K) inhibitors as potential anti-inflammatory agents
4 of 20
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
5 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
6 of 20
Targeted protein degradation as a new approach to drug discovery
7 of 20
New chemical approaches for the development of targeted protein degradation
8 of 20
The development of chemo- and regioselective reactions of boron systems
9 of 20
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
10 of 20
The design and synthesis of novel epigenetic modulators
11 of 20
Preclinical development of a treatment for systemic lupus erythematosus
12 of 20
The use of contemporary chemoproteomic techniques in antimalarial target identification
13 of 20
Investigations of the synthesis and properties of romodomain and extra-terminal domain proteolysis targeting chimeras
14 of 20
New hydrogen atom transfer methodologies for synthesis
15 of 20
The design, synthesis and optimisation of kinase inhibitors as potential anti-inflammatory agents
16 of 20
The design, synthesis and optimisation of epigenetic mechanism inhibitors
17 of 20
Sustainable cross-couplings for pharmaceutical scale-up using aryldiazonium salts
18 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
19 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
20 of 20